← Back to Search

Goal Management Training (GMT) for Post-Traumatic Stress Disorder

N/A

Waitlist Available

Led By Ruth A. Lanius, MD, PhD

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will test a new treatment for PTSD called Goal Management Training, to see if it can help with the cognitive problems associated with the disorder, as well as the symptoms themselves.

Eligible Conditions

Post Traumatic Stress Disorder
Cognitive Impairment
Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Clinician Administered PTSD Scale (CAPS) score from baseline to post-treatment assessment

Change in Clinician Administered PTSD Scale (CAPS) score from post-treatment to 3-month follow-up assessment

Change in Difficulties in Emotion Regulation Scale (DERS) score from baseline to post-treatment assessment

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Goal Management Training (GMT)Experimental Treatment1 Intervention

Participants in this arm will attend 9 weekly, 2-hour group GMT appointments.

Group II: Wait ListActive Control1 Intervention

Participants in this arm will receive no treatment for approximately 21 weeks (at which point, they will be offered the same, standard GMT treatment).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor

656 Previous Clinical Trials

413,428 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,338 Previous Clinical Trials

25,751,518 Total Patients Enrolled

FDC FoundationOTHER

2 Previous Clinical Trials

11 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the requirements to join this experiment?

"This clinical trial has a quota of 50 participants that have experienced cognitive deterioration, with ages varying between 18 and 65. To be eligible for the program, applicants must meet specific requirements: access to electronic devices equipped with microphone and webcam, reliable internet connection, private space where assessments can take place; PTSD diagnosis confirmed by preliminary assessment; fluency in English language; residency within Ontario due to legal restrictions."

Answered by AI

Is it possible to register for this clinical research right now?

"Clinicaltrials.gov currently states that this investigation is no longer enrolling patients. It was initially posted on December 1st 2022, and the most recent update occurred on August 29th 2022. Fortunately, there are 1043 other medical trials actively recruiting subjects as of now."

Answered by AI

Are people of over two decades in age being welcomed to participate in this experiment?

"This clinical trial requires that participants are aged 18 to 65 years old. Additionally, there are 73 trials for paediatric patients and 912 studies involving elderly individuals."

Answered by AI